Zai Lab is an innovative biopharmaceutical company based in China and the U.S., focused on delivering transformational outcomes to patients around the world.
This weekend, we're at #ASCO26, highlighting the ongoing trial evaluating our investigational treatment for small-cell lung cancer. Read more here: https://t.co/oCCBtyiPjl
#Breaking: The U.S. FDA granted Fast Track designation to our experimental targeted antibody-drug conjugate for extrapulmonary neuroendocrine carcinomas. Learn more about this milestone: https://t.co/NH1uJASlZl
#NEWS: Dr. Thummalapalli speaks to @ecancer about early-phase results evaluating zoci, a novel DLL3-targeting antibody-drug conjugate, in patients with advanced neuroendocrine carcinomas who have progressed after platinum-based chemotherapy. @rohit_thum https://t.co/pumCHJaK7P
#Breaking at #AAI2026: We're sharing positive preclinical study results from our investigational bispecific antibody in atopic dermatitis and other disease models. Learn more: https://t.co/5UZ4XUu0Vd
At #AACR26, we will present data demonstrating the progress of our #oncology pipeline, including important new data for our investigational treatment for people with small-cell lung cancer. Learn more: https://t.co/LzMpqVvHac
#NEWS: We announced a clinical collaboration with @Boehringer to pioneer a potential dual DLL3-targeting investigational combination for small-cell lung cancer and other neuroendocrine carcinomas.
Learn more: https://t.co/KUfJpD2br9 #SLC#Innovation#Oncology
#NEWS: Zai Lab will present new data on three internally developed oncology candidates at #AACR26, including zoci (DLL3 ADC), ZLโ6201 (LRRC15 ADC), and ZLโ1222 (PDโ1/ILโ12).
Learn more: https://t.co/CSLtjhXQUK #ADC#Oncology#Immunotherapy
#NEWS: Zai Lab announces fourth quarter and full-year 2025 financial results along with recent product highlights and corporate updates.
Learn more about our pipeline progress and healthcare innovation: https://t.co/rygJwdik7C
#earnings#financialresults#oncology#ADC
Celebrating five years of partnership with @argenxglobal. Together, weโve accelerated development, expanded patient access, and supported thousands across Chinaโincluding those living with gMG and CIDP. Grateful for our teams driving impact and innovation forward. #LifeSciences
#NEWS: Zai Lab will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco today @ 3PM PT / 6PM ET. Learn more about our 2026 strategic priorities and global pipeline progress: https://t.co/bKMfKzmpZp
#JPM26#Innovation#ADC#oncology
#NEWS: Zai Lab dosed the first participant in our Global Phase 1/1b study of ZL-1503, a potential first-in-class IL-13/IL-31R bispecific antibody for the treatment of atopic dermatitis. Discover the potential of ZL-1503: https://t.co/6qnfYTdGuQ
Zai Lab's President and COO Josh Smiley spoke at @FinancialTimes Global Pharma and Biotech Summit in London today on a panel discussing China's transformation into a biopharma innovation powerhouse.
#FTPharma#Innovation#Biotech#BioPharma
#NEWS: Zai Lab announces third quarter 2025 financial results along with recent product highlights and corporate updates.
Learn more about our pipeline progress and healthcare innovation: https://t.co/CXJsAYDaWn
#earnings#financialresults#oncology#ADC#healthcare#innovation
#NEWS: Zai Lab announces updated data from the global Ph1 clinical trial of zocilurtatug pelitecan (zoci)โformerly ZL-1310โ today at the AACR-NCI-EORTC International Conference. Learn more about the initiation of our global Ph3 Registrational Study: https://t.co/uHphQ512JV
#ADC
#NEWS: Zai Lab will deliver an oral presentation featuring updated data from our global Phase 1 trial of zocilurtatug pelitecan (ZL-1310) at the upcoming 2025 AACR-NCI-EORTC Conference in Boston. Visit: https://t.co/guOksRR36H
#ESSCLC#DLL3#ADC#Targets25#LungCancer
Join us in recognizing #WorldMentalHealthDay.
At Zai Lab, we stand with the global community in raising awareness and reducing stigma around mental health.
Join the movement to advocate for mental health worldwide: https://t.co/MbFYgR9WmK
This #WorldLungDay, Zai Lab reaffirms its commitment to advancing awareness of lung health and the global impact of lung diseases, including lung cancer.
Join the global movement to protect, promote, and prioritize lung health: https://t.co/GH3SABsHNP